World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc
Journal website http://www.wjnu.org

Original Article

Volume 1, Number 2-3, June 2012, pages 79-84

Prevalence of Aspirin Resistance in Patients of Chronic Kidney Disease

Tables

Table 1. : Baseline Demographic Data and Clinical Characteristics of Patients Participated in the Study
 
ParametersMean ± S.D
Age (years)65.03 ± 9.02
Male : Female99:27
BMI (kg/m2)27.78 ± 4.30
Patients with Diabetes67
Patients with Hypertension96
Patients with Hyperlipidemia56
Smoker37
Systolic Blood Pressure (mmHg)147.6 ± 17.4
Diastolic Blood Pressure (mmHg)93.1 ± 7.7
Fasting Blood Sugar (mg/dL)115.89 ± 19.96
HDL (mg/dL)54.42 ± 9.98
LDL (mg/dL)157.53 ± 25.82
TGL (mg/dL)166.35 ± 31.25
TC (mg/dL)210.2 ± 21.73
Fibrinogen (g/L)2.16 ± 0.36
Creatinine Clerance (mL/min)35.50 ± 12.02

 

Table 2. : Comparison Between Aspirin Sensitive and Aspirin Resistant Group to 100 mg Aspirin Taken Daily for 4 Weeks
 
ParametersAspirin Sensitive (n = 87)Aspirin Resistance (n =39)P value
Age (years)64.37 ± 9.1265.70 ± 8.990.57
Male : Female70:1729:100.69
BMI (kg/m2)26.27 ± 3.5729.30 ± 4.490.005*
Diabetes42250.1
Hypertension64360.03*
Hyperlipidemia34220.05*
Smoker22150.20
SBP (mmHg)146.42 ± 18.32148.76 ± 16.920.83
DBP (mm Hg)92.71 ± 7.0193.57 ± 8.40.43
Fasting Blood Sugar (mg/dL)108.67 ± 21.16123.11 ± 17.010.01*
HDL (mg/dL)55.25 ± 8.0953.38 ± 11.890.69
LDL (mg/dL)147.2 ± 21.13167.87 ± 34.070.05*
TGL (mg/dL)162.27 ± 34.13171.43 ± 27.630.43
TC (mg/dL)255.27 ± 36.48210.20 ± 21.730.61
Fibrinogen (g/L)2.01 ± 0.322.31 ± 0.400.04*
Creatinine Clerance (mL/min)39.88 ± 10.8731.13 ± 13.830.05*